GROENHUYSEN WILHELMUS CM 4
4 · NovoCure Ltd · Filed Jun 7, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
GROENHUYSEN WILHELMUS CM
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2024-06-05$22.82/sh−124,373$2,838,192→ 95,000 total(indirect: By Trust)Exercise: $7.15Exp: 2027-02-21→ Ordinary Shares (124,373 underlying) - Exercise/Conversion
Ordinary Shares
2024-06-05$22.82/sh+124,373$2,838,192→ 124,373 total(indirect: By Trust)
Holdings
- 251,235
Ordinary Shares
Footnotes (2)
- [F1]Options to buy 219,372 ordinary shares will vest in equal installments on each of February 22, 2018, 2019 and 2020, subject to the reporting person's continued employment through such dates.
- [F2]By The 2020 Groenhuysen Annuity Trust. Mr. Groenhuysen does not disclaim beneficial ownership.